THIOREDOXIN-INTERACTING PROTEIN IN ENDOTHELIAL AND ORGANISMAL METABOLISM
THIOREDOXIN-INTERACTING PROTEIN IN ENDOTHELIAL AND ORGANISMAL METABOLISM
批准号:
8250448
负责人:
RICHARD T LEE
金额:
$41.06万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2015-03-31
关键词:
AffectArrestinsBindingBlood VesselsCardiovascular DiseasesCell LineCell SurvivalCellsClinicalCollaborationsComplexDataDiabetes MellitusDisulfidesEndocytosisEndothelial CellsEnvironmentEventFamilyFunctional disorderG-Protein-Coupled ReceptorsGTP-Binding ProteinsGene ExpressionGenesGlutathioneHyperglycemiaIn VitroInflammatory ResponseLiquid substanceMediatingMediator of activation proteinMetabolicMetabolismMutagenesisOxidation-ReductionOxidative StressOxidoreductasePPAR gammaPathway interactionsProtein BindingProteinsReactive Oxygen SpeciesReceptor SignalingRecyclingRegulationResearch PersonnelResearch Project GrantsRoleSignal TransductionStagingStructureSulfhydryl CompoundsSystemTestingThioredoxinTissuesUbiquitinationVascular DiseasesYeastsbeta-arrestinbiological adaptation to stresscell growthdesensitizationdisulfide bondenergy balanceglucose metabolismin vivoinhibitor/antagonistinsulin sensitivitylipid biosynthesislipid metabolismmemberoxidationreceptorresearch studyscaffoldshear stresstheoriesvascular inflammation
中文摘要
alpha arrestin家族包括研究得最好的成员Txnip和其他五种功能未知的蛋白质。Txnip最初被认为是血管氧化还原状态的调节剂。由于Txnip是由高血糖诱导的,并且Txnip可以抑制硫氧还蛋白,许多研究者提出高血糖通过Txnip介导的硫氧还蛋白抑制来诱导氧化应激。然而,令人信服的证据表明,Txnip是与血管疾病相关的多种信号事件的关键调节剂。
由于Txnip可以与还原的硫氧还蛋白(但不氧化)形成混合二硫键复合物,
因此,Txnip可以作为氧化还原敏感性信号传导调节剂而不是简单地作为硫氧还蛋白的抑制剂发挥作用。我们的初步数据表明,Txnip是葡萄糖和脂质代谢,胰岛素敏感性,脂肪形成和能量平衡的重要介质。在这里,我们提出的数据支持的中心假设,Txnip是一个关键的细胞内信号调节,Txnip的功能是不可能仅仅是由于抑制硫氧还蛋白。我们提出了三个Alms,将定义Txnip在内皮细胞中的作用:AIM 1。明确Txnip和硫氧还蛋白相互作用在内皮细胞炎症反应中的作用。在这里,我们将测试的假设,Txnip在调节血管炎症反应的作用是依赖于特定的分子相互作用与硫氧还蛋白通过分子间二硫键。AIM 2.明确Txnip的结构-功能关系。我们提出了Txnip的特定结构域调节葡萄糖代谢的初步数据;使用β抑制蛋白的已知结构,
我们将定义Txnip的特定区域以及调节葡萄糖代谢和内皮剪切应力反应的其它α抑制蛋白。目的3:验证Txnip通过PPAR-gamma依赖性机制调节内皮细胞代谢的假说。我们将确定Txnip对PPAR-gamma功能的影响是否依赖于硫氧还蛋白,并检验Txnip在体内因果影响PPAR-gamma功能的假设。最后,我们将在体内探索Txnip影响PPAR-gamma功能以通过内皮细胞表达介导全身代谢调节的概念。
英文摘要
The alpha arrestin family includes the best studied member, Txnip, and five other proteins with unknown functions. Txnip was originally considered a regulator of vascular redox state. Because Txnip is induced by hyperglycemia, and Txnip can inhibit thioredoxin, many investigators have proposed that hyperglycemia Induces oxidative stress through Txnip-mediated inhibition of thioredoxin. However, compelling evidence has now emerged that Txnip is a critical regulator of diverse signaling events relevant to vascular disease.
Because Txnip can form a mixed disulfide complex with reduced thioredoxin (but not oxidized
thioredoxin),Txnip may function as a redox-sensitive signaling regulator rather than simply as an inhibitor of thioredoxin. Our preliminary data show that Txnip is an important mediator of glucose and lipid metabolism, insulin sensitivity, adipogenesis, and energy balance. Here we present data supporting the central hypothesis that Txnip is a critical intracellular signaling regulator, and that Txnip's functions are unlikely to be solely due to inhibition of thioredoxin. We propose three Alms that will define the role of Txnip in endothelial cells: AIM 1. To define the role of the interaction of Txnip and thioredoxin in the inflammatory response of endothelial cells. Here we will test the hypothesis that the role of Txnip In the regulation of the vascular inflammatory response is dependent on the specific molecular interaction with thioredoxin through an Intermolecular disulfide bond. AIM 2. To define structure-function relations of Txnip. We present preliminary data that specific domains of Txnip regulate glucose metabolism; using the known structure of beta arrestins,
we will define specific regions of Txnip as well as other alpha arrestins that regulate glucose metabolism and the endothelial shear stress response. AIM 3:To test the hypothesis that Txnip regulates metabolism in vivo via a PPAR-gamma dependent mechanism in endothelial cells. We will determine whether Txnip's ihipact on PPAR-gamma function is dependent on thioredoxin and test the hypothesis that Txnip causally influences PPAR-gamma function in vivo. Finally, we will explore in vivo the concept that Txnip impacts PPAR-gamma function to mediate whole body metabolic regulation through endothelial cell expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Myocardial Physiology of Growth Differentiation Factor Signaling
-
批准号:10711086
-
项目类别:
-
资助金额:$60.85万
-
财政年份:2023
-
负责人:RICHARD T LEE
-
依托单位:
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism
-
批准号:10320336
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2021
-
负责人:RICHARD T LEE
-
依托单位:
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism
-
批准号:10095220
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2021
-
负责人:RICHARD T LEE
-
依托单位:
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism
-
批准号:10540314
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2021
-
负责人:RICHARD T LEE
-
依托单位:
Molecular Quiescence and Cardiomyocyte Maturation
-
批准号:10371079
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2020
-
负责人:RICHARD T LEE
-
依托单位:
In vivo Structure-Function relationships of GDF11 and GDF8
-
批准号:10246575
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2020
-
负责人:RICHARD T LEE
-
依托单位:
Molecular Quiescence and Cardiomyocyte Maturation
-
批准号:10589890
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2020
-
负责人:RICHARD T LEE
-
依托单位:
Myocardial Effects of Caloric Restriction in Primates
-
批准号:9507133
-
项目类别:
-
资助金额:$8.45万
-
财政年份:2018
-
负责人:RICHARD T LEE
-
依托单位:
Complement Activation and Initiation of Heart Regeneration
-
批准号:10116444
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2018
-
负责人:RICHARD T LEE
-
依托单位:
Myocardial Effects of Caloric Restriction in Primates
-
批准号:9764223
-
项目类别:
-
资助金额:$8.45万
-
财政年份:2018
-
负责人:RICHARD T LEE
-
依托单位:
Reprogramming Non-myocytes to Cardiomyocytes in vivo
-
批准号:9493517
-
项目类别:
-
资助金额:$42.78万
-
财政年份:2016
-
负责人:RICHARD T LEE
-
依托单位:
Regulation of Fructose Transport by Thioredoxin-Interacting Protein
-
批准号:9171070
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2016
-
负责人:RICHARD T LEE
-
依托单位:
Reprogramming Non-myocytes to Cardiomyocytes in vivo
-
批准号:9173755
-
项目类别:
-
资助金额:$44.51万
-
财政年份:2016
-
负责人:RICHARD T LEE
-
依托单位:
A New Pathway for Reversing Cardiac Aging
-
批准号:9266761
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2015
-
负责人:RICHARD T LEE
-
依托单位:
Biasing Myocardial Neuregulin Signaling with Engineered Ligands
-
批准号:8720813
-
项目类别:
-
资助金额:$41.07万
-
财政年份:2013
-
负责人:RICHARD T LEE
-
依托单位:
Biasing Myocardial Neuregulin Signaling with Engineered Ligands
-
批准号:8576906
-
项目类别:
-
资助金额:$39.8万
-
财政年份:2013
-
负责人:RICHARD T LEE
-
依托单位:
Engineering a Cell-Based Glucose Monitor
-
批准号:8633822
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2013
-
负责人:RICHARD T LEE
-
依托单位:
Cardiomyocyte Lineage and Turnover by Metabolic Fate-Mapping
-
批准号:8318592
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2011
-
负责人:RICHARD T LEE
-
依托单位:
Cardiomyocyte Lineage and Turnover by Metabolic Fate-Mapping
-
批准号:8464620
-
项目类别:
-
资助金额:$35.95万
-
财政年份:2011
-
负责人:RICHARD T LEE
-
依托单位:
Cardiomyocyte Lineage and Turnover by Metabolic Fate-Mapping
-
批准号:8150793
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2011
-
负责人:RICHARD T LEE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AT1R-G蛋白/β-arrestins通路偏好性激活在急性肾损伤中的作用及其机制
-
批准号:82104272
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:贾英丽
-
依托单位:
催产素受体Gαq与β-arrestins偏爱型信号通路在产后抑郁症中的作用
-
批准号:82104148
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:朱佳蕾
-
依托单位:
β-arrestins在DC细胞迁移及自身免疫疾病中的作用及机制研究
-
批准号:31871404
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:杜昌升
-
依托单位:
β-arrestins调节小胶质细胞M1/M2表型转化及其在阿尔兹海默病进程中的作用
-
批准号:81703488
-
项目类别:青年科学基金项目
-
资助金额:20.1万元
-
批准年份:2017
-
负责人:方吟荃
-
依托单位:
β-arrestins保护心肌梗死的作用和机制研究
-
批准号:81670260
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:刘冲
-
依托单位:
beta-arrestins在自感光神经节细胞光信号转导中的作用和机制研究
-
批准号:31601134
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:赵欢
-
依托单位:
支气管上皮细胞恶性转化中β-arrestins的作用及其机制研究
-
批准号:81301728
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:申洪昌
-
依托单位:
β-arrestins通过ER stress/Puma调控门脉高压性胃病的机制
-
批准号:81370511
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2013
-
负责人:吴斌
-
依托单位:
β-arrestins在缺血再灌注性肝损伤及其修复中的作用和机制
-
批准号:81170422
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:汪根树
-
依托单位:
β-arrestins介导甘丙肽2型受体信号转导的作用机理及其可能的抗抑郁机制
-
批准号:31171032
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:徐志卿
-
依托单位: